1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,540 | 1,720 | 09.01. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.12.25 | IKONISYS: Number of shares and voting rights of Ikonisys SA as of December 23, 2025 | 1 | Euronext | ||
| 19.12.25 | Aliko Scientific raises €2.72 million through private placement and debt conversion | 1 | Investing.com | ||
| 19.12.25 | Ikonisys SA: Ikonisys finalized a Capital Increase and Debt Conversion of EUR 2.72 million with strategic investment from Avantgarde Srl and Alberto Previtali | 344 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 04.12.25 | Ikonisys SA: Ikonisys: Cytofast Auto: The First Fully Automatic Universal Monolayer Cytology Processor Is Born | 273 | Business Wire | Regulatory News:
Hospitex international, the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices... ► Artikel lesen | |
| IKONISYS Aktie jetzt für 0€ handeln | |||||
| 24.11.25 | Ikonisys SA: Ikonisys: Hospitex Initiates International Dialogues for Pilot Projects in Oncology Diagnostics Following ADB Delegation Visit | 385 | Business Wire | Regulatory News:
Hospitex, the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices, announces... ► Artikel lesen | |
| 07.10.25 | Ikonisys SA: Hospitex Wins Public Tender at Policlinico di Bari for Cytofast Cytology Systems | 252 | Business Wire | Regulatory News:
Hospitex,the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices, has been... ► Artikel lesen | |
| 30.09.25 | XFRA 9W8: WIEDERAUFNAHME/RESUMPTION | 147 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 01.07.25 | Ikonisys SA: Suspension of Trading of Shares on Euronext Growth Paris Until the Publication of the 2024 Annual Report | 339 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 01.07.25 | XFRA 9W8: AUSSETZUNG/SUSPENSION | 340 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIKONISYS EO 2 9W8... ► Artikel lesen | |
| 04.06.25 | ALIKO SCIENTIFIC (Ikonisys SA), Through Its Fully Owned Italian Subsidiary Hospitex International, Signs Exclusive Distribution Agreement for Italy with Menarini Diagnostics | 339 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) Euronext Growth: ALIKO, through its fully owned Italian subsidiary Hospitex International is pleased to announce the signing of an exclusive distribution... ► Artikel lesen | |
| 30.05.25 | Ikonisys SA: Ikonisys Announces a Further Postponement of the Publication of Its 2024 Annual Financial Report | 355 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 02.05.25 | Ikonisys SA: Ikonisys Finalized a Capital Increase Through the Offsetting of Debt | 373 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 25.04.25 | Ikonisys Announces the Postponement of the Publication of Its 2024 Annual Financial Report | 326 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution... ► Artikel lesen | |
| 03.04.25 | Ikonisys SA: Hospitex International Launches Urine24, the First-Online Urinary Cytology Test Platform, Marking a Breakthrough in Early Bladder Cancer Diagnosis in Italy | 392 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), announces that its Italian subsidiary Hospitex International has launched Urine24.com, the first online-available... ► Artikel lesen | |
| 10.03.25 | Ikonisys SA Wins Public Tender with F. Miulli Regional General Hospital for Pathological Anatomy | 341 | Business Wire | Regulatory News:
Hospitex, the Italian leader in the production of Cytology medical devices and fully owned subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company... ► Artikel lesen | |
| 27.02.25 | Ikonisys SA: Ikonisys Finalized a Capital Increase Through a Private Placement | 609 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 05.02.25 | Ikonisys' Subsidiary Hospitex Secures a Major UN-Funded Contract for Hospital IT and Networking Systems in Ethiopia | 552 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that its subsidiary Hospitex, the Italian leader in the production of medical devices, has secured... ► Artikel lesen | |
| 27.01.25 | Ikonisys Secures U.S. Patent for "Automated Fluorescence Microscopy Method to Determine the Efficacy of Cancer and Hyperplasia Treatments" | 467 | Business Wire | Regulatory News:
Ikonisys Inc., a leader in advanced cell-based diagnostic solutions fully owned by ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), is proud to announce the grant... ► Artikel lesen | |
| 15.01.25 | Ikonisys: Hospitex Secures Major Public Tender for "Gaetano Martino" University Hospital in Messina | 352 | Business Wire | Regulatory News:
Hospitex, the Italian leader in the production of medical devices and a subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that it has... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,510 | -0,04 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,500 | +1,26 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| FRESENIUS | 49,230 | -1,05 % | dpa-AFX-Überblick: UNTERNEHMEN vom 09.01.2026 - 15.15 Uhr | ROUNDUP: Teamviewer erreicht Umsatzziel für 2025 - Aktie mit Erholungsversuch GÖPPINGEN - Der Softwareanbieter Teamviewer hat 2025 sein im Herbst gesenktes Umsatzziel knapp erreicht. Basierend auf... ► Artikel lesen | |
| BETA BIONICS | 20,550 | -35,76 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,620 | -3,74 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,260 | -1,01 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| PROGYNY | 26,990 | -1,64 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten | ||
| GERRESHEIMER | 27,400 | +0,37 % | Bechtle, Gerresheimer, HelloFresh, Kontron, Lanxess, TUI - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,755 | -0,93 % | Where Alignment Healthcare Stands With Analysts | ||
| CLEARPOINT NEURO | 14,950 | -2,35 % | ClearPoint Neuro schließt Zustimmungsvereinbarung zur Restrukturierung von IRRAS AB | ||
| GENEDX | 135,54 | -1,32 % | GeneDx partners with Komodo Health to create comprehensive rare disease dataset | ||
| PROCEPT BIOROBOTICS | 32,840 | -4,76 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| LUMEXA IMAGING | 16,840 | -5,02 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| INTELLIGENT BIO SOLUTIONS | 18,055 | +24,43 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| HEARTFLOW | 33,200 | -0,81 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen |
IKONISYS gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,060 (-3,69 %) liegt der Kurs bei 1,565 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IKONISYS finden Sie auf Wallstreet Online.